33.200
−1,19%
2026-10-19
Fundamental Analysis
43 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -15.2% | -14.9% | 1 / 3 | +13.3% | -0.60 pp | -0.85 pp | +28.8% | 1.46 | 3.93 | 1.484 | +13,3% | 135 | +3,7% | 3.93 | 4.98 | −21,2% |
| Pts | 0 | 0 | 4 | 4 | 4 | 4 | 12 | 6 | 12 | |||||||
Valuation annotation:Price: 33.200 (close price on 2026-10-19)EPS (TTM): 8.458
Financial charts
1.Revenue & growth
VND bn1.484Q2/26
1.Revenue & growth
VND bn1.484Q2/26
2.Profit & growth
VND bn131Q2/26
3.Profit mix (Penman)
VND bn408Q2/26
4.Margins & cost structure
%11.7%Q2/26
5.Returns & cash cycle
% · days18.5%Q2/26
6.Earnings quality & cash
VND bn385Q2/26
7.Asset structure
VND bn4.129Q2/26
8.Funding & debt health
VND bn · times4.129Q2/26
9.Revenue backlog
VND bn11,0Q2/26
10.Valuation
times · %4,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %3.647Q2/26
Adjusted EPS growth, latest quarter
1.8%
Average adjusted EPS growth, 3 quarters
-9.2%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26